We discuss the highlights for the CPM in 2023-24, and look forward to the next year.

What might it be like to navigate a genetic diagnosis and share it with family members? We talk to Julie Young from the CanGene CanVar patient reference panel about her experience.

As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work for ensuring ethical practice in genomics? We talk to Dr Kate Lyle about her research on this topic.

What are the ethical challenges with diversifying genomic data? We talk to Faranak Hardcastle about her work exploring this.

We live our lives alongside others, and our decisions have consequences for those close to us - what does this mean for how we define 'the patient' in genomic medicine? Susie Weller talks to us about this issue.

What sort of findings might we get from newborn genome screening? What might this mean for the NHS? Rachel Horton talks to Gabby Samuel and Lisa Ballard.

Who does a genetic result belong to? What might help people to share genetic information with their relatives? We talk to Lisa Ballard and Anneke Lucassen.

How can the same genetic finding can mean different things in different people? What does this mean for 'personalising' genetic results? Anneke Lucassen talks to us about this issue.

In this episode, Dr Rachel Horton and Dr Gabby Samuel talk to Professor Anneke Lucassen about why the same genetic finding can mean different things for different people, and discuss what this means for ‘personalising’ genetic results. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

How does personalised medicine impact on the environment? What does this mean for how we should collect and store data? Gabrielle Samuel talks to us about these issues. A transcript of this episode is available at https://media.podcasts.ox.ac.uk/medsci/cpm/2022-06-15-medsci-cpm-s2-ep-1.pdf